Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Top Cited Papers
- 1 October 2009
- journal article
- review article
- Published by American Society for Microbiology in Clinical Microbiology Reviews
- Vol. 22 (4) , 582-610
- https://doi.org/10.1128/cmr.00040-09
Abstract
SUMMARY: Treatment of infectious diseases becomes more challenging with each passing year. This is especially true for infections caused by the opportunistic pathogenPseudomonas aeruginosa, with its ability to rapidly develop resistance to multiple classes of antibiotics. Although the import of resistance mechanisms on mobile genetic elements is always a concern, the most difficult challenge we face withP. aeruginosais its ability to rapidly develop resistance during the course of treating an infection. The chromosomally encoded AmpC cephalosporinase, the outer membrane porin OprD, and the multidrug efflux pumps are particularly relevant to this therapeutic challenge. The discussion presented in this review highlights the clinical significance of these chromosomally encoded resistance mechanisms, as well as the complex mechanisms/pathways by whichP. aeruginosaregulates their expression. Although a great deal of knowledge has been gained toward understanding the regulation of AmpC, OprD, and efflux pumps inP. aeruginosa, it is clear that we have much to learn about how this resourceful pathogen coregulates different resistance mechanisms to overcome the antibacterial challenges it faces.This publication has 302 references indexed in Scilit:
- H-NS family members function coordinately in an opportunistic pathogenProceedings of the National Academy of Sciences, 2008
- The crystal structure of MexR from Pseudomonas aeruginosa in complex with its antirepressor ArmRProceedings of the National Academy of Sciences, 2008
- The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanismProceedings of the National Academy of Sciences, 2008
- Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006)Diagnostic Microbiology and Infectious Disease, 2007
- Multidrug-resistance efflux pumps ? not just for resistanceNature Reviews Microbiology, 2006
- Emerging epidemic of metallo-β-lactamase–mediated resistancesDiagnostic Microbiology and Infectious Disease, 2005
- Metallo-β-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: Continued prevalence of VIM-producing pseudomonas spp. and increase of IMP-producing Acinetobacter sppDiagnostic Microbiology and Infectious Disease, 2004
- Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospitalDiagnostic Microbiology and Infectious Disease, 2004
- Changes of microbial flora and wound colonization in burned patientsBurns, 2004
- Cell-to-Cell Signaling and Pseudomonas aeruginosa InfectionsEmerging Infectious Diseases, 1998